New AI platform designed to support faster discovery, better study design, and earlier diagnosis using unstructured clinical data

Briya, a health technology company focused on transforming data-driven medical research, has unveiled Briya AIRE, a clinical-grade artificial intelligence platform developed to support biomedical and epidemiological research across the healthcare ecosystem.

The launch positions AIRE as the first AI research environment designed specifically to “think” in the language of medicine, enabling clinicians and researchers to accelerate hypothesis testing, identify hidden data patterns, and build cohorts using unstructured clinical records.

Unlike traditional AI tools that synthesise data outputs, AIRE serves as a virtual epidemiologist and research assistant. It guides users through the research process by refining study parameters, generating validated questions, and surfacing insights grounded in peer-reviewed science.

“Incorporating Briya AIRE into research and clinical practice has the potential to revolutionise medical care,” said Dr Robert Brown, Vincent Astor distinguished professor of medicine and chief of the division of gastroenterology and hepatology at Weill Cornell Medicine. “Using AI to collate patient data and clinical evidence will allow physicians to make better decisions in a more efficient and timely manner while reducing administrative burden so they can spend more time interacting with and thinking about their patients.”

AIRE is currently being used by academic medical centres and biopharma organisations to support research across a range of therapeutic areas. One example includes its use in identifying patients with metabolic dysfunction-associated steatohepatitis (MASH) at risk of progressing to cirrhosis through automated analysis of imaging reports and unstructured text.

“Using the advanced NLP capabilities, we can now accurately identify patients with MASH at significant risk of progressing to severe liver damage or cirrhosis, directly from unstructured clinical data across the healthcare ecosystem,” said Dr Gadi Lalazar, head of the liver unit at Shaare Zedek Medical Center. “This ability to automatically analyse imaging reports opens the door to earlier interventions for these high-risk patients, and spells promise for its use in a wide range of indications.”

Built on Briya’s secure infrastructure, AIRE integrates with hospital systems, clinical research databases, and physicians’ notes. Researchers can ask questions in natural language, which are translated into scientifically valid outputs using built-in epidemiological frameworks and published evidence. The system is designed to reduce the need for coding expertise and eliminate repetitive data preparation.

“Life-saving research should never be delayed because researchers and physicians are expected to become program coders,” said David Lazerson, co-founder and chief executive officer of Briya. “Unlike general-purpose AI tools, Briya AIRE has been built specifically for clinical and biomedical researchers to ask questions in plain language, instantly translated into epidemiologically valid and scientifically precise requests. The outcome is an accelerated research journey.”

AIRE meets US and European privacy standards and is designed to support secure, compliant research at scale.